About I AM ALS
I AM ALS is a Healthcare company based in Washington DC, United States. A non-profit organization focused on ALS support and advocacy is operated. It operates on a Donation / Grant-Based model. I AM ALS offers products and services including ALS Support Services, Advocacy and Policy Reform, and Peer Support and Community Building. Its focus areas include Non-Profit Organizations and Disease Support.
Company details
I AM ALS is dedicated to supporting individuals and families affected by Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrigs disease. Comprehensive resources, peer support, and virtual support groups are provided to empower patients and caregivers. Advocacy for policy reform and increased federal funding for ALS research is actively pursued. Collaboration with policymakers and community-driven initiatives are emphasized to improve access to treatments and build supportive networks. The organization operates within the healthcare and non-profit sector, focusing on creating systemic change and accelerating the search for a cure.
Products & Services of I AM ALS
I AM ALS offers a comprehensive portfolio of products and services, including ALS Support Services, Advocacy and Policy Reform, and Peer Support and Community Building.
Support services for ALS patients are provided comprehensively.
Advocacy for ALS policy changes is actively pursued.
Peer support for ALS community is consistently offered.
Apps and channels of I AM ALS
its YouTube channel I AM ALS has 1.61K subscribers and 30 videos.
Videos from I AM ALS
The most watched videos on I AM ALS's YouTube channel, I AM ALS (1.61K subscribers). Click a video to play it here.
More on I AM ALS.
People of I AM ALS
22 people are tracked at I AM ALS (4 in leadership, 11 in board & advisors, 7 in team).
| Name | Role | Group |
|---|---|---|
Michael Lecker | Vice President Of Organizing | Leadership |
Sonya Sotak Elling | Chief Government Affairs Officer | Leadership |
Andrea Goodman | CEO | Leadership |
Aditi Narayan Minkoff | VP of Community Support | Leadership |
Dan Tate, Jr. | Board Member | Board & advisors |
Louise Langheier | Board chair | Board & advisors |
Brian Wallach | Co-Founder | Board & advisors |
Peter Bowen | Board member | Board & advisors |
Sandra Abrevaya | Co-Founder | Board & advisors |
Jano Cabrera | Board member | Board & advisors |
Neel Parekh | Board Member | Board & advisors |
Juan A. Reyes | Board Member | Board & advisors |
Peggy Plews-Ogan | Board Member | Board & advisors |
Michael O’Neil | Board Member | Board & advisors |
Jenny Fortner | Board Member | Board & advisors |
Holly Curtis | Community Organizing Associate | Team |
Philip Green | Patient Advocate | Team |
Juliet Taylor | Co-chair, Community Engagement Team (volunteer) | Team |
Osiel Mendoza | Community Outreach Team Member | Team |
Patrick Nicholas | ALS Support Lead | Team |
2 more people are available in the full profile.
Complete people profiles for I AM ALS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Web traffic of I AM ALS
Websites that share an audience with I AM ALS (iamals.org).
Websites whose visitors overlap most with I AM ALS. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| als.org | 78% | 149.8K | #291,369 | View details |
Top companies in Rare Diseases
3 companies that operate in the same segment as I AM ALS (Rare Diseases), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about I AM ALS
I AM ALS is dedicated to supporting individuals and families affected by Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrigs disease. Comprehensive resources, peer support, and virtual support groups are provided to empower patients and caregivers. Advocacy for policy reform and increased federal funding for ALS research is actively pursued. Collaboration with policymakers and community-driven initiatives are emphasized to improve access to treatments and build supportive networks. The organization operates within the healthcare and non-profit sector, focusing on creating systemic change and accelerating the search for a cure.
I AM ALS offers ALS Support Services, Advocacy and Policy Reform, and Peer Support and Community Building.